Objective response rate of placebo in randomized controlled trials of anticancer medicines

BACKGROUND: Spontaneous regression of advanced solid tumors is infrequent but may occur. Quantifying response rates from placebo in cancer drug trials may provide important information for physicians, patients, and regulators. We aimed to provide a pooled placebo response rate from drug trials in ad...

Descripción completa

Detalles Bibliográficos
Autores principales: Sachdev, Arushi, Sharpe, Isobel, Bowman, Meghan, Booth, Christopher M., Gyawali, Bishal
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9700265/
https://www.ncbi.nlm.nih.gov/pubmed/36444211
http://dx.doi.org/10.1016/j.eclinm.2022.101753

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9700265/
https://www.ncbi.nlm.nih.gov/pubmed/36444211
http://dx.doi.org/10.1016/j.eclinm.2022.101753

Ejemplares similares